Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

PLoS Pathogens(2022)10.1371/journal.ppat.1010465Source: DataRank Database

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.26)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (34)

Suprit Deshpande ORCID,Payel Das ORCID,Zaigham Abbas Rizvi ORCID,Constantinos Kurt Wibmer ORCID,Poppy Mashilo

Live enrichment

PubMed:35482816 PMC:PMC9089897 OpenAlex:https://openalex.org/W4226049994

Research Council of Norway

Grant: 285136

Developing HIV broadly neutralising antibodies as a prevention product for global access through antibody half-life extension engineering.

Department of Biotechnology, Ministry of Science and Technology

Grant: BT/PR40401/BIOBANK/03/2020

Bill and Melinda Gates Foundation

Grant: OPP1170236 and INV-004923

GIST Cancer Research Fund

Grant: Flair Fellowship Program FLR/R1/201782

Fogarty International Center

Grant: 3R21TW011454-02S1

Rational structure-guided design of broadly reactive next-generation therapeutics to treat non-communicable snakebite in Africa

FIC NIH HHS

Grant: R21 TW011454

International AIDS Vaccine Initiative

FWCI

1.26

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010465&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010465&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1010465

journalhttps://doi.org/10.1371/journal.ppat.1010465

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35482816

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral gastroenteritis research and epidemiologyAnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralCOVID-19MiceSARS-CoV-2Spike Glycoprotein, CoronavirusSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2AnimalsAntibodies, MonoclonalAntibodies, ViralMiceAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

Monoclonal antibodyVirologyPandemicAntibodyEpitopeNeutralizationNeutralizing antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirusBiologyImmunologyMedicineInfectious disease (medical specialty)DiseaseInternal medicineQH301-705.5SARS-CoV-2Antibodies, MonoclonalCOVID-19RC581-607Antibodies, ViralAntibodies, NeutralizingMiceSpike Glycoprotein, CoronavirusAnimalsImmunologic diseases. AllergyBiology (General)Research Article

Sustainable Development Goals

SDG 3: 3. Good health